China Biotech Services Holdings Limited (HKG:8037)
Hong Kong · Delayed Price · Currency is HKD 0.6100
-0.0050 (-0.81%)
Sep 11, 2026, 2:53 PM HKT
HKG:8037 Financials Overview
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 85.86 | 73.5 | 70.51 | 211.99 | 1,852 | 623.76 |
Revenue Growth | 16.82% | 4.25% | -66.74% | -88.55% | 196.83% | -4.88% |
Gross Profit Gross Profit Growth | 9.15 | 7.73 | -4.94 | 34.32 | 1,101 | 358.02 |
Operating Income Operating Income Growth | -80.78 | -73.86 | -123.77 | -116.86 | 842.9 | 189.54 |
Net Income Net Income Growth | -18.54 | -68.78 | -198.15 | -95.45 | 258.09 | 19.39 |
Earnings Per Share EPS Growth | -0.02 | -0.07 | -0.20 | -0.10 | 0.27 | 0.02 |
EPS Growth | - | - | - | - | 1233.42% | -35.49% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
BNCT BNCT Growth | - | 0.15 | - | - | - | - |
Insurance Brokerage Insurance Brokerage Growth | 23.45 | 37.57 | 30.6 | 18.16 | 6.93 | 7.92 |
Others Others Growth | -0.09 | 0.15 | 0.14 | 3.74 | 13.52 | 7.96 |
Pharmaceutical Products Pharmaceutical Products Growth | - | - | 1.22 | 2.57 | 281.21 | 0.11 |
Medical and Health Related Services Medical and Health Related Services Growth | - | 36.83 | 39.61 | 193.07 | 1,622 | 607.78 |
Intersegment Intersegment Growth | - | -1.2 | -1.06 | -5.57 | -72.54 | - |
Total Total Growth | 85.86 | 73.5 | 70.51 | 211.99 | 1,852 | 623.76 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 47.15 | 12.08 | 18.91 | 72.09 | 92.77 | 152.31 |
Total Debt Total Debt Growth | 461.88 | 394.9 | 187.83 | 100.4 | 81.78 | 67.17 |
Net Cash (Debt) Net Cash Growth | -414.74 | -382.82 | -168.92 | -28.31 | 10.99 | 85.14 |
Net Cash Growth | - | - | - | - | -87.10% | -69.53% |
Net Cash Per Share Net Cash Per Share Growth | -0.43 | -0.39 | -0.17 | -0.03 | 0.01 | 0.09 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | - | -45.98 | -151.89 | 191.72 | 482.75 | 40.51 |
Capital Expenditures CapEx Growth | - | -142.11 | -51.65 | -59.41 | -108.17 | -12.22 |
Free Cash Flow Free Cash Flow Growth | - | -188.09 | -203.54 | 132.31 | 374.58 | 28.29 |
Free Cash Flow Growth | - | - | - | -64.68% | 1224.12% | -90.42% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 10.66% | 10.51% | -7.01% | 16.19% | 59.46% | 57.40% |
Operating Margin | -94.08% | -100.48% | -175.54% | -55.13% | 45.52% | 30.39% |
Pretax Margin | -36.08% | -111.15% | -358.53% | -67.00% | 46.60% | 28.96% |
Profit Margin | -21.59% | -93.57% | -281.02% | -45.02% | 13.94% | 3.11% |
FCF Margin | - | -255.89% | -288.67% | 62.41% | 20.23% | 4.54% |
| Fiscal Year | FY 2022 |
|---|---|
| Period Ending | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.010 |
Dividend Per Share Growth | - |
Dividend Yield | 0.88% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 4.29 | 68.57 |
P/FCF Ratio | - | - | - | 5.61 | 2.96 | 46.99 |
PS Ratio | 6.99 | 10.49 | 7.06 | 3.50 | 0.60 | 2.13 |